SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-16-005331
Filing Date
2016-05-11
Accepted
2016-05-11 16:38:49
Documents
57
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q s103199_10q.htm 10-Q 340940
2 EXHIBIT 31.1 s103199_ex31-1.htm EX-31.1 7145
3 EXHIBIT 31.2 s103199_ex31-2.htm EX-31.2 7081
4 EXHIBIT 32.1 s103199_ex32-1.htm EX-32.1 4034
5 EXHIBIT 32.2 s103199_ex32-2.htm EX-32.2 4058
  Complete submission text file 0001615774-16-005331.txt   3064042

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE avxl-20160331.xml EX-101.INS 655951
7 XBRL SCHEMA FILE avxl-20160331.xsd EX-101.SCH 37178
8 XBRL CALCULATION FILE avxl-20160331_cal.xml EX-101.CAL 39494
9 XBRL DEFINITION FILE avxl-20160331_def.xml EX-101.DEF 153538
10 XBRL LABEL FILE avxl-20160331_lab.xml EX-101.LAB 279867
11 XBRL PRESENTATION FILE avxl-20160331_pre.xml EX-101.PRE 215452
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 161640402
SIC: 8731 Services-Commercial Physical & Biological Research